CDC: Monitoring of COVID-19 will remain a priority
May 08, 2023
Surveillance of COVID-19 and COVID-19-associated mortality after expiration of the COVID-19 public health emergency declaration on May 11 will continue.
Incidence of fatigue, chronic fatigue increased significantly after COVID-19 infection
Feb 21, 2024
An increased risk was seen for fatigue and chronic fatigue, with hazard ratios of 1.68 and 4.32 compared with non-COVID-19 controls.
Adverse events after BNT162b2 do not differ for cancer patients
Feb 08, 2022
Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment.
Simultaneous flu vaccine, COVID-19 booster safe
Jul 21, 2022
Systemic reactions generally were mild and were slightly more likely among those receiving both vaccines compared with the COVID-19 mRNA booster alone.
Abnormal ventilatory patterns common after COVID-19 infection
Dec 09, 2021
Patients with postacute sequelae of SARS-CoV-2 infection also have circulatory impairment and myalgic encephalomyelitis/chronic fatigue.
Immunoglobulin G spike receptor binding domain antibody levels were similar after the primary series and booster dose.
SARS-CoV-2 reinfection more likely in unvaccinated individuals
Aug 09, 2021
Individuals unvaccinated against COVID-19 were more likely to be reinfected in May to June 2021 after prior infection in 2020.
Almost 30 percent of COVID-19 patients develop ‘long COVID’
May 02, 2022
Factors independently associated with PASC include hospitalization for COVID-19, having diabetes and higher body mass index.
Concerns raised about COVID-19 chronic olfactory dysfunction
Nov 19, 2021
“These data suggest an emerging public health concern of OD and the urgent need for research that focuses on treating COVID-19 COD,” the authors wrote.
mRNA-1273 continues to be efficacious at five months
Sep 27, 2021
The efficacy of mRNA-1273, the Moderna vaccine, was 93.2% for preventing COVID-19 illness and 98.2% for preventing severe COVID-19.